Sanitas
AB "Sanitas" is one of the oldest and largest pharmaceutical companies in Lithuania. The company produces and markets non-proprietary medicinal products – injection preparations, tablets, capsules, eye drops. It was acquired by Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) in 2011. History. Sanitas was established in 1922. As a public limited liability company Sanitas was registered in the Republic of Lithuania in 1994. In the same year its shares were listed on the National Securities Exchange. From 19 August 2011 the controlling shareholding (99.4 percent) in AB Sanitas is held by Valeant Pharmaceuticals International. The General Manager of  the company is Saulius Mečislovas Žemaitis, the company currently employs about 110 people. Products. Sanitas manufacturing capacities allow producing various forms of medicines – tablets, capsules, ampoules, eye drops and complicated preparations that create value added – disposable filled syringes. The company bases its activities on the European Good Manufacturing Practice (GMP) – high quality assurance standards that guarantee consistency in creating, manufacturing, investigating preparations so that they would correspond to their purpose, the requirements of the marketing authorization certificate and of the specifications. Sanitas manufactures products of about 50 different names. Among medicinal products marketed in Lithuania are Neocitramonas, Paracetamolis Sanitas, Neoaskofenas , Ranitidinas Sanitas, Panogastin, Latalux, Ecriten, Eufilinas Sanitas, Askorbo rūgštis Sanitas, Analginas Sanitas, Ketolgan, Alkostop and other prescription and over-the-counter medications. All the products of the Sanitas group are divided according to therapeutic areas: